|
risk factor screening and counseling).
Interventions reviewed were zyrtec single-component (i.e., using only one activity to achieve desired outcomes) or multicomponent (i.e., using more than one related activity). Interventions were grouped together on the basis of their similarity. Some studies provided evidence for zyrtec than one.
effectiveness does not result in recommendations regarding an intervention's use but is important for identifying areas of uncertainty and continuing research needs. In contrast, adequate evidence zyrtec ineffectiveness leads to zyrtec recommendation that the intervention not be used.
The systematic search zyrtec 243 studies on tobacco interventions that met the inclusion criteria. Of these 243 studies, 77 were excluded on the basis of limitations in their execution zyrtec design and were not considered further. The remaining 166 studies were considered qualifying zyrtec zyrtec 14 Task Force evaluations in this report are based on these qualifying studies, all of which had good or fair execution.
On the basis of the evidence of zyrtec the Task Force either strongly recommended or recommended nine of the 14 strategies evaluated (Table 2). These nine recommendations include one intervention to reduce exposure to ETS (smoking bans and restrictions), two interventions to reduce tobacco-use.
and tobacco industry and product restrictions --- are still under way and will be included in the finished chapter. zyrtec OF THE RECOMMENDATIONS.
|